These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12419502)

  • 21. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage.
    Martens-Lobenhoffer J; Sulyok E; Czeiter E; Büki A; Kohl J; Firsching R; Tröger U; Bode-Böger SM
    J Neurosci Methods; 2007 Aug; 164(1):155-60. PubMed ID: 17512604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
    Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
    J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis.
    Danilov AI; Andersson M; Bavand N; Wiklund NP; Olsson T; Brundin L
    J Neuroimmunol; 2003 Mar; 136(1-2):112-8. PubMed ID: 12620649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
    Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
    J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.
    Spies PE; Melis RJ; Sjögren MJ; Rikkert MG; Verbeek MM
    J Alzheimers Dis; 2009; 16(2):363-9. PubMed ID: 19221426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis.
    Asahara H; Yokoi I; Tamada T; Kabuto H; Ogawab N; Mori A; Inoue H
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):77-83. PubMed ID: 8824933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies.
    Slaets S; Le Bastard N; Theuns J; Sleegers K; Verstraeten A; De Leenheir E; Luyckx J; Martin JJ; Van Broeckhoven C; Engelborghs S
    J Alzheimers Dis; 2013; 35(1):137-46. PubMed ID: 23364139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
    Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
    Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy.
    Peltola J; Ukkonen M; Moilanen E; Elovaara I
    Neurology; 2001 Sep; 57(5):895-6. PubMed ID: 11552025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache.
    Steinberg A; Wiklund NP; Brundin L; Remahl AI
    Cephalalgia; 2010 Jun; 30(6):696-702. PubMed ID: 20511209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria.
    Agbenyega T; Angus B; Bedu-Addo G; Baffoe-Bonnie B; Griffin G; Vallance P; Krishna S
    Trans R Soc Trop Med Hyg; 1997; 91(3):298-302. PubMed ID: 9231201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
    Aerts MB; Esselink RA; Claassen JA; Abdo WF; Bloem BR; Verbeek MM
    J Alzheimers Dis; 2011; 27(2):377-84. PubMed ID: 21841257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dementia with Lewy bodies: cerebrospinal fluid suppresses neuronal network activity.
    Theiss S; Maetzler W; Deuschle C; Lerche H; Koch H; Dihné M
    Neuroreport; 2017 Nov; 28(16):1061-1065. PubMed ID: 28953602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    Morimoto S; Takao M; Hatsuta H; Nishina Y; Komiya T; Sengoku R; Nakano Y; Uchino A; Sumikura H; Saito Y; Kanemaru K; Murayama S
    PLoS One; 2017; 12(2):e0171524. PubMed ID: 28166276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.
    Nielsen HM; Hall S; Surova Y; Nägga K; Nilsson C; Londos E; Minthon L; Hansson O; Wennström M
    J Alzheimers Dis; 2014; 40(2):343-50. PubMed ID: 24448788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
    Nielsen HM; Palmqvist S; Minthon L; Londos E; Wennström M
    Curr Alzheimer Res; 2012 Mar; 9(3):257-66. PubMed ID: 22191565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
    Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
    Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM
    J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.